JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2018, Vol. 32 ›› Issue (2): 103-106.doi: 10.6040/j.issn.1673-3770.0.2017.543

Previous Articles     Next Articles

Advances in diagnosis and treatment of polypoid choroidal vasculopathy

WANG Xian1, LI Ying2, ZHAO Bojun3   

  1. Department of Geriatrics, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;3. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, Shandong, China
  • Received:2017-12-24 Online:2018-03-20 Published:2018-03-20

Abstract: Polypoid choroidal vasculopathy(PCV)is characterized by visible orange lesions on fundoscopy. Indocyan-nine green angiograph depicts one or more hyperfluorescent polypoid lesions, with or without abnormal branching vasculature, and also serous and hemorrhagic retinal pigment epithelial detachment. Because of its unique clinical features and higher incidence, increasing attention is being paid to PCV. With advances in science and medical technology, new screening devices, therapies, and drugs are being adopted, all of which has led to a new phase in the understanding, diagnosis, and treatment of PCV. This article reviews the progress of PCV in terms of its diagnosis and treatment.

Key words: Polypoidal choroidal vasculopathy, Diagnosis, Treatment

CLC Number: 

  • R774
[1] Yannuzzi LA, Sorenson J, Spaide RF, et al. Idiopathic polypoidal choroidal vasculopathy(IPCV)[J]. Retina, 1990, 10(1):1-8.
[2] Lim S, Cheung CMG, Wong TY. Asian age-related macular degeneration[J]. Asia Pac J Ophthalmol, 2013, 2(1):32-41.
[3] Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics[J]. Arch Ophthalmol, 2003, 121(10):1392-1396.
[4] Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy:an angiographic discussion[J]. Eye, 2010, 24(3):483-490.
[5] Wong CW, Wong TY. Polypoidal choroidal vasculopathy in Asians[J]. J Clin Med, 2015, 4:782-821.
[6] Wong CW, Yanagi Y, Lee WK, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians[J]. Prog Retin Eye Res, 2016, 53:107-139.
[7] 颜昕,王翠,赵博军. 息肉状脉络膜血管病变的临床表现分析[J]. 山东大学耳鼻喉眼学报,2017,31(4):98-102. YAN Xin, WANG Cui, ZHAO Bojun. Clinical manifestations of polypoidal choroidal vasculopathy[J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(4):98-102.
[8] Li Y, You QS, Wei WB, et al. Polypoidal choroidal vasculopathy in adult chinese: the Beijing eye study[J]. Ophthalmol, 2014, 121(11):2290-2291.
[9] Koh AH, Chen LJ, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment[J]. Retina, 2013, 33(4):686-716.
[10] Desmettre T, Devoisselle JM, Mordon S. Fluorescence properties and metabolic features of indocyanine green(ICG)as related to angiography[J]. Surv Ophthalmol, 2000, 45(1):15-27.
[11] Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review[J]. Surv Ophthalmol, 2010, 55(6): 501-515.
[12] Coppens G, Spielberg L, Leys A. Polypoidal choroidal vasculopathy,diagnosis and management[J]. Bull Soc Belge Ophtalmol, 2011(317):39-44.
[13] Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2005, 89(5): 602-607.
[14] Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography[J]. Retina, 2009, 29(1):52-59.
[15] Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy[J]. Retina, 2007, 27(5):589-594.
[16] De Salvo G, Vaz Pereira S, Keane PA, et al. Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2014, 158(6):1228-1238.
[17] Chang YS, Kim JH, Kim JW, et al. Optical coherence tomography-based diagnosis of polypoidal choroidal vasculopathy in korean patients[J]. Kor J Ophthalmol, 2016, 30(3):198.
[18] 张怡,姚静,王肖华,等. 光学相干断层扫描诊断息肉状脉络膜血管病变的敏感性和特异性[J]. 南方医科大学学报,2017,37(2):165-171. ZHANG Yi, YAO Jing, WANG Xiaohua, et al. Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy [J]. J Sout Med Univ, 2017, 37(2):165-171.
[19] Tomiyasu T, Nozaki M, Yoshida M, et al. Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):324-330.
[20] Kim JY, Kwon OW, Oh HS, et al. Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy[J]. Graefes Arch Clin Exp Ophthalmo, 2016, 254(8):1505-1510.
[21] Inoue M, Balaratnasingam C, Freund KB. Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization[J]. Retina, 2015, 35(11):2265-2274.
[22] Wang M, Zhou Y, Gao SS, et al. Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9):526-532.
[23] Takayama K, Ito Y, Kaneko H, et al. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy[J]. Eye, 2017, 31(1):45-52.
[24] Wong IY, Shi X, Gangwani R, et al. One-year results of half- versus standard-dose photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy[J]. Retina, 2017. DOI: 10.1097/IAE.0000000000001614.
[25] Hikichi T. Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy[J]. Br J Ophthalmol, 2018, 102(1):97-101.
[26] 杨景元,王尔茜,陈有信.光动力疗法与玻璃体腔注射抗血管内皮生长因子制剂治疗息肉样脉络膜血管病变的Meta分析[J].中华眼底病杂志,2016,32(1):73-78. YANG Jingyuan, WANG Erqian, CHEN Youxin, et al. Meta-analysis of photodynamic therapy and intravitreal injection of anti-vascular endothelial growth factor agent in the treatment of polypoid choroidal vasculopathy[J]. Chin J Ocul Fund Dis, 2016, 32(1):73-78.
[27] Koh A, Lee WK, Chen LJ, et al. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy[J]. Retina, 2012, 32(8):1453-1464.
[28] Gomi F, Sawa M, Wakabayashi T, et al. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2010, 150(1):48-54.
[29] Koh A, Lai TYY, Takahashi K, et al. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial[J]. JAMA Ophthalmol, 2017, 135(11):1206-1213.
[1] SHEN Qinfeng, SHEN Xiaoyan, ZHU Rongqiang, JIANG Feifei, LANG Juntian. Role of functional middle turbinectomy in functional endoscopic sinus surgery for chronic sinusitis [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 82-85.
[2] ZHU Mingjuan, XING Kai, KANG Zefeng, LIU Jian. Diagnosis and treatment of thyroid-associated ophthalmopathy [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 110-113.
[3] DAI Yacuo, LI Jing, WAN Baoluo, ZANG Yanzi, HUANG Yingming. Individualized treatment of pharyngeal and laryngeal cavernous hemangioma:a report of two cases. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 110-112.
[4] LIU Yiping, LIN Yuanchao. Use of negative pressure drainage for prevention of salivary fistula after parotidectomy: an analysis of 112 cases [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 65-67.
[5] ZHANG Guimin, LIN Peng. Endotype of chronic rhinosinusitis: from basic to clinical research [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 14-17.
[6] ZHONG Jianwen, LIU Dabo, LUO Xiangqian, HUANG Zhenyun, QIU Shuyao, CHENG Chao, YANG Liqiang, YI Xinhua, ZENG Jinhong. The application of wearable devices in the diagnosis of children obstructive sleep apnea [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 30-33.
[7] GAO Jinliang, NIAN Wanqing, LI Shuo. Evaluation of the clinical curative effect of nose surgery in combination with nasal corticosteroids in [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 38-42.
[8] LÜ Dan, LI Mingxia, MA Lanzhi, ZHANG Xinyuan, XIAO Hao, CHEN Fei, LIU Jun, LI Zhen. Neurofibromatosis of the head and neck involving the mediastinum: two cases report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 82-86.
[9] LI Qiaoli, LI Chao, WANG Wei, CAI Yongcong, SUN Ronghao, ZHOU Yuqiu, SHUI Chunyan, HUANG Lu, TU Jing. Primary squamous cell carcinoma of the parotid gland with recurrence and invasion of lateral skull base after radiotherapy and chemotherapy: one case report [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 87-88.
[10] CHEN Hong, CAO Huiling, DOU Xin, GAO Xia. Small cell neuroendocrine carcinoma in the right nasal cavity: a report of one case and a literature review [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 89-92.
[11] WANG Zhixiang, XUE Kai, WEI Ning, HAN Shuang, JIN Chunshun.. A case of recurrent laryngeal nerve schwannoma misdiagnosed as a thyroid tumor. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(6): 33-35.
[12] SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben. Standardization of the diagnosis and treatment of anaplastic thyroid carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 16-20.
[13] JING Shanglin.. Diagnosis and treatment of upper airway cough syndrome in children. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2017, 31(6): 87-91.
[14] ZHANG Yubo, YUE Liyan, YIN Xiaoyan, LÜ Zhe, SHAN Chunguang. Effect of tinnitus treatment instrument combined with Ginkgo biloba extract on hearing and hemorheology in patients with sudden deafness and tinnitus. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 50-53.
[15] MA Zhaoen, ZHAI Jinming, LIAO Libing, YANG Zhen. Short-term effect of eustachian tube balloon dilation in the treatment of chronic otitis media with effusion. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 54-56.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!